Clariane's Stock Rises by 2.4% Targeting a Key Resistance at €4.35
In the mid-afternoon, the personal services group's stock accelerates and is among the top gainers in the SBF 120. The movement brings it back into contact with a key zone tested last week, as the broader index also advances during the session.
A Technical Rebound Brings the Stock Back to Its €4.35 Resistance
Clariane's stock gains 2.4% to €4.26, ranking among the highest risers in the SBF 120, which is up by 0.67% at the same time. The stock rises above its 20-day and 50-day moving averages, both at €4.07, with a gap of nearly 5% confirming the recovery initiated over several sessions. The 200-day moving average, at €3.94, also remains below the current price, providing a cushion of over 8%. The RSI at 57 remains neutral, indicating that the movement is not yet in an overheated zone. The stock thus comes back into contact with its resistance at €4.35, which was previously challenged on June 19 during an earlier surge of 4.25%, without a clear breakthrough at this stage. Over three months, the stock has accumulated a gain of nearly 22%, while the performance over one year remains negative at -11.7%.
The Issuance of €333 Million in Hybrid Bonds Puts Refinancing Back in the Spotlight
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The background remains marked by the issuance of €333 million in perpetual subordinated hybrid bonds launched on June 22, aimed at refinancing existing ODIRNANE. This operation is part of the group's debt management strategy and fuels the bullish momentum observed on the stock for several weeks. The movement occurs in a Parisian market trending upwards, with the CAC 40 progressing by 0.67% and the VIX decreasing to 17.84 (-8.5%), reflecting a climate of reduced risk aversion following the easing in oil prices. The next technical milestone now plays out on whether the €4.35 threshold is breached or not: breaking through it would pave the way for an extension of the rebound, while a failure would bring the stock back to its moving averages around €4.07.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 1T2026
Key reported figures
Revenue: 1336M€
Guidance from the release
Avec une croissance organique de 4,9 %, le premier trimestre 2026 s’inscrit pleinement dans la dynamique.
Le chiffre d’affaires au 31 mars 2026 s’établit à €1 336m, en progression de +4,9%.
Risks mentioned
Impact des cessions intervenues en 2025 dans le cadre du plan de renforcement.
Risque lié aux conditions de marché futures.
Effets des défis réglementaires dans le secteur.
Opportunities identified
Lancement d'une obligation senior de €500m à échéance 2031.
Nouvelle dynamiqueprix/volume grâce aux mesures d’adaptation mises en place.
Engagement fort des collaborateurs pour atteindre les objectifs opérationnels.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.